Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNX-102 SL in Military-Related PTSD
NCT02277704Phase 2Completed
- Sponsor
- Tonix Pharmaceuticals
- Start
- Oct 2014
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Tonmya in post-traumatic stress disorder (PTSD), sponsored by Tonix Pharmaceuticals. Started Oct 2014; status: completed.
02
Drugs
Tonmya
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02277704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02277704.